|
1
|
Thakker RV, Newey PJ, Walls GV, Bilezikian
J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F and Brandi
ML: Endocrine Society. Clinical practice guidelines for multiple
endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab.
97:2990–3011. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ito T, Igarashi H, Uehara H, Berna MJ and
Jensen RT: Causes of death and prognostic factors in multiple
endocrine neoplasia type 1: A prospective study. comparison of 106
MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1
patients with or without pancreatic endocrine tumors. Medicine
(Baltimore). 92:135–181. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Basuroy R, Bouvier C, Ramage JK, Sissons
M, Kent A and Srirajaskanthan R: Presenting symptoms and delay in
diagnosis of gastrointestinal and pancreatic neuroendocrine
tumours. Neuroendocrinology. 107:42–49. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yamazaki M, Suzuki S, Kosugi S, Okamoto T,
Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, et al: Delay
in the diagnosis of multiple endocrine neoplasia type 1: Typical
symptoms are frequently overlooked. Endocr J. 59:797–807.
2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
De Laat JM, van Leeuwaarde RS and Valk GD:
The importance of an early and accurate MEN1 diagnosis. Front
Endocrinol (Lausanne). 9(533)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Moraes AB, Treistman N, Studart MC, Chagas
VLA, Brabo EP and Vieira Neto L: Gastrinoma of cystic duct: A rare
association with multiple endocrine neoplasia type 1. J Clin Med
Res. 10:843–847. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sakurai A, Suzuki S, Kosugi S, Okamoto T,
Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, et al:
Multiple endocrine neoplasia type 1 in Japan: Establishment and
analysis of a multicentre database. Clin Endocrinol (Oxf).
76:533–539. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lourenço DM Jr, Toledo RA, Coutinho FL,
Margarido LC, Siqueira SA, dos Santos MA, Montenegro FL, Machado MC
and Toledo SP: The impact of clinical and genetic screenings on the
management of the multiple endocrine neoplasia type 1. Clinics (Sao
Paulo). 62:465–476. 2007.PubMed/NCBI
|
|
9
|
Lourenço DM Jr, Toledo RA, Mackowiak II,
Coutinho FL, Cavalcanti MG, Correia-Deur JE, Montenegro F, Siqueira
SA, Margarido LC, Machado MC and Toledo SP: Multiple endocrine
neoplasia type 1 in Brazil: MEN1 founding mutation, clinical
features, and bone mineral density profile. Eur J Endocrinol.
159:259–274. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Carty SE, Helm AK, Amico JA, Clarke MR,
Foley TP, Watson CG and Mulvihill JJ: The variable penetrance and
spectrum of manifestations of multiple endocrine neoplasia type 1.
Surgery. 124:1106–1113. 1998.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Christopoulos C, Antoniou N, Thempeyioti
A, Calender A and Economopoulos P: Familial multiple endocrine
neoplasia type I: The urologist is first on the scene. BJU Int.
96:884–887. 2005.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pieterman CR, Schreinemakers JM,
Koppeschaar HP, Vriens MR, Rinkes IH, Zonnenberg BA, van der Luijt
RB and Valk GD: Multiple endocrine neoplasia type 1 (MEN1): Its
manifestations and effect of genetic screening on clinical outcome.
Clin Endocrinol (Oxf). 70:575–581. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vergès B, Boureille F, Goudet P, Murat A,
Beckeres A, Sassolas G, Goudard P, Chambe B, Montvernay C and
Calender A: Pituitary disease in MEN type 1 (MEN1): Data from the
france-belgium MEN1 multicenter study. J Clin Endocrinol Metabol.
87:457–465. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
de Laat JM, Tham E, Pieterman CR, Vriens
MR, Dorresteijn JA, Bots ML, Nordenskjöld M, van der Luijt RB and
Valk GD: Predicting the risk of multiple endocrine neoplasia type 1
for patients with commonly occurring endocrine tumors. Eur J
Endocrinol. 167:181–87. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Burgess JR, David R, Parameswaran V,
Greenaway TM and Shepherd JJ: The outcome of subtotal
parathyroidectomy for the treatment of hyperparathyroidism in
multiple endocrine neoplasia type 1. Arch Surg. 133:126–129.
1998.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Eller-Vainicher C, Chiodini I, Battista C,
Viti R, Mascia ML, Massironi S, Peracchi M, D'Agruma L, Minisola S,
Corbetta S, et al: Sporadic and MEN1-related primary
hyperparathyroidism: Differences in clinical expression and
severity. J Bone Miner Res. 24:1404–1410. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lourenço DM Jr, Coutinho FL, Toledo RA,
Montenegro FL, Correia-Deur JE and Toledo SP: Early-onset,
progressive, frequent, extensive, and severe bone mineral and renal
complications in multiple endocrine neoplasia type 1-associated
primary hyperparathyroidism. J Bone Miner Res. 25:2382–2391.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Lourenço DM Jr, Coutinho FL, Toledo RA,
Gonçalves TD, Montenegro FL and Toledo SP: Biochemical, bone and
renal patterns in hyperparathyroidism associated with multiple
endocrine neoplasia type 1. Clinics (Sao Paulo). 67(Suppl
1):S99–S108. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Giusti F, Cianferotti L, Boaretto F,
Cetani F, Cioppi F, Colao A, Davì MV, Faggiano A, Fanciulli G,
Ferolla P, et al: Multiple endocrine neoplasia syndrome type 1:
Institution, management, and data analysis of a nationwide
multicenter patient database. Endocrine. 58:349–359.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Reid TJ, Post KD, Bruce JN, Nabi Kanibir
M, Reyes-Vidal CM and Freda PU: Features at diagnosis of 324
patients with acromegaly did not change from 1981 to 2006:
Acromegaly remains under-recognized and under-diagnosed. Clin
Endocrinol (Oxf). 72:203–208. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tonelli F, Fratini G, Falchetti A, Nesi G
and Brandi ML: Surgery for gastroenteropancreatic tumours in
multiple endocrine neoplasia type 1: Review and personal
experience. J Intern Med. 257:38–49. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
van Leeuwaarde RS, van Nesselrooij BP,
Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN,
Drent ML, Bisschop PH, Havekes B, Vriens MR, et al: Impact of delay
in diagnosis in outcomes in MEN1: Results from the dutch MEN1 study
group. J Clin Endocrinol Metab. 101:1159–1165. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Toledo RA, Sekiya T, Longuini VC, Coutinho
FL, Lourenço DM Jr and Toledo SP: Narrowing the gap of personalized
medicine in emerging countries: The case of multiple endocrine
neoplasias in Brazil. Clinics (Sao Paulo). 67(Suppl 1):S3–S6.
2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Toledo RA, Lourenço DM Jr, Coutinho FL,
Quedas E, Mackowiack I, Machado MC, Montenegro F, Cunha-Neto MB,
Liberman B, Pereira MA, et al: Novel MEN1 germline mutations in
Brazilian families with multiple endocrine neoplasia type 1. Clin
Endocrinol (Oxf). 67:377–384. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Coutinho FL, Lourenço DM Jr, Toledo RA,
Montenegro FL, Correia-Deur JE and Toledo SP: Bone mineral density
analysis in patients with primary hyperparathyroidism associated
with multiple endocrine neoplasia type 1 after total
parathyroidectomy. Clin Endocrinol (Oxf). 72:462–468.
2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Dantas NCB, Soares CEL, Martins MRA,
Lourenço DM Jr and Quidute ARP: Giant prolactinoma causing
hydrocephalus and intracranial hypertension as first manifestations
of multiple endocrine neoplasia type 1. Front Endocrinol
(Lausanne). 10(582)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Montenegro FLM, Brescia MDG, Lourenço DM
Jr, Arap SS, d'Alessandro AF, de Britto E, Silva Filho G and Toledo
SPA: Could the less-than subtotal parathyroidectomy be an option
for treating young patients with multiple endocrine neoplasia type
1-related hyperparathyroidism? Front Endocrinol (Lausanne).
10(123)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Carvalho RA, Urtremari B, Jorge AAL,
Santana LS, Quedas EPS, Sekiya T, Longuini VC, Montenegro FLM,
Lerario AM, Toledo SPA, et al: Germline mutation landscape of
multiple endocrine neoplasia type 1 using full gene next-generation
sequencing. Eur J Endocrinol. 179:391–407. 2018.PubMed/NCBI View Article : Google Scholar
|
